Flagship Ventures Fund IV
Latest statistics and disclosures from Flagship Ventures Fund IV's latest quarterly 13F-HR filing:
- Central Index Key (CIK): 0001503559
Portfolio Holdings for Flagship Ventures Fund IV
Flagship Ventures Fund IV holds 3 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Seres Therapeutics (MCRB) | 98.0 | $374M | 14M | 26.56 |
|
|
| T2 Biosystems | 1.9 | $7.3M | 742k | 9.86 |
|
|
| Eleven Biotherapeutics | 0.1 | $469k | 1.5M | 0.32 |
|
Past Filings by Flagship Ventures Fund IV
SEC 13F filings are viewable for Flagship Ventures Fund IV going back to 2016
- Flagship Ventures Fund IV 2016 Q1 restated filed June 3, 2016
- Flagship Ventures Fund IV 2016 Q1 filed May 13, 2016